Content:
Overview
Content on this page:
Overview
Content on this page:
Overview
Overview
Pulmonary tuberculosis (PTB) is a case of tuberculosis that involves the lung parenchyma.
Definite tuberculosis (TB) is considered in patients with culture, molecular tests positive for Mycobacterium tuberculosis, or in patients with at least one sputum smear positive for acid-fast bacilli.
Most common symptom of pulmonary tuberculosis is cough ≥2 weeks that is productive and may be accompanied by both/either: Respiratory symptoms: Shortness of breath, chest pains, hemoptysis and constitutional symptoms: Loss of appetite, unexplained weight loss, fever, night sweats, fatigue.
Essential principles of care for persons with active or suspected TB include: Prompt and accurate diagnosis, use of standardized and effective treatment regimen plus proper treatment support and supervision and monitor treatment response.
Initial or intensive phase is when combination drugs are used to rapidly kill replicating populations of M tuberculosis and occurrence of drug resistance is prevented. Bactericidal effect leads to fast conversion of bacteriological sputum and improvement in clinical symptoms. Continuation phase is when drugs slowly and intermittently kill replicating populations. Remaining bacteria are eliminated and consequent relapse is prevented.
Treatment regimen for new TB patients consists of first-line anti-TB agents: Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E).
For further information regarding the management of Tuberculosis - Pulmonary, please refer to Disease Algorithm for the Treatment Guideline.
Definite tuberculosis (TB) is considered in patients with culture, molecular tests positive for Mycobacterium tuberculosis, or in patients with at least one sputum smear positive for acid-fast bacilli.
Most common symptom of pulmonary tuberculosis is cough ≥2 weeks that is productive and may be accompanied by both/either: Respiratory symptoms: Shortness of breath, chest pains, hemoptysis and constitutional symptoms: Loss of appetite, unexplained weight loss, fever, night sweats, fatigue.
Essential principles of care for persons with active or suspected TB include: Prompt and accurate diagnosis, use of standardized and effective treatment regimen plus proper treatment support and supervision and monitor treatment response.
Initial or intensive phase is when combination drugs are used to rapidly kill replicating populations of M tuberculosis and occurrence of drug resistance is prevented. Bactericidal effect leads to fast conversion of bacteriological sputum and improvement in clinical symptoms. Continuation phase is when drugs slowly and intermittently kill replicating populations. Remaining bacteria are eliminated and consequent relapse is prevented.
Treatment regimen for new TB patients consists of first-line anti-TB agents: Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E).
For further information regarding the management of Tuberculosis - Pulmonary, please refer to Disease Algorithm for the Treatment Guideline.
